ROMA illuminates CLL genomic lesions

被引：2

作者：

Caligaris-Cappio, Federico ^{[1
]}

机构：

[1] Univ Sci Inst San Raffaele, San Rafael, CA USA

来源：

BLOOD | 2009年 / 113卷 / 06期

关键词：

CHRONIC LYMPHOCYTIC-LEUKEMIA; DISEASE; PROGRESSION;

D O I：

10.1182/blood-2008-11-190579

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

In this issue of Blood, Grubor and colleagues investigate genomic changes in a large series of patients with CLL. They report novel genetic lesions, ascertain the frequency of losses and gains of genomic areas with greater accuracy, track down candidate genes, and analyze intraclonal heterogeneity.

引用

页码：1209 / 1210

页数：2

共 8 条

[1]

Novel insights in chronic lymphocytic leukemia: Are we getting closer to understanding the pathogenesis of the disease? [J].

Caligaris-Cappio, Federico ;

Ghia, Paolo .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (27) :4497-4503

[2]

Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia [J].

Calin, GA ;

Dumitru, CD ;

Shimizu, M ;

Bichi, R ;

Zupo, S ;

Noch, E ;

Aldler, H ;

Rattan, S ;

Keating, M ;

Rai, K ;

Rassenti, L ;

Kipps, T ;

Negrini, M ;

Bullrich, F ;

Croce, CM .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (24) :15524-15529

[3]

A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia [J].

Calin, GA ;

Ferracin, M ;

Cimmino, A ;

Di Leva, G ;

Shimizu, M ;

Wojcik, SE ;

Iorio, MV ;

Visone, R ;

Sever, NI ;

Fabbri, M ;

Iuliano, R ;

Palumbo, T ;

Pichiorri, F ;

Roldo, C ;

Garzon, R ;

Sevignani, C ;

Rassenti, L ;

Alder, H ;

Volinia, S ;

Liu, CG ;

Kipps, TJ ;

Negrini, M ;

Croce, CM .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (17) :1793-1801

[4]

Mechanisms of disease: Chronic lymphocytic leukemia [J].

Chiorazzi, N ;

Rai, KR ;

Ferrarini, M .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (08) :804-815

[5]

miR-15 and miR-16 induce apoptosis by targeting BCL2 [J].

Cimmino, A ;

Calin, GA ;

Fabbri, M ;

Iorio, MV ;

Ferracin, M ;

Shimizu, M ;

Wojcik, SE ;

Aqeilan, RI ;

Zupo, S ;

Dono, M ;

Rassenti, L ;

Alder, H ;

Volinia, S ;

Liu, CG ;

Kipps, TJ ;

Negrini, M ;

Croce, CM .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (39) :13944-13949

[6]

Genomic aberrations and survival in chronic lymphocytic leukemia. [J].

Döhner, H ;

Stilgenbauer, S ;

Benner, A ;

Leupolt, E ;

Kröber, A ;

Bullinger, L ;

Döhner, K ;

Bentz, M ;

Lichter, P .

NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (26) :1910-1916

[7]

The pattern of CD38 expression defines a distinct subset of chronic lymphocytic leukemia (CLL) patients at risk of disease progression [J].

Ghia, P ;

Guida, G ;

Stella, S ;

Gottardi, D ;

Geuna, M ;

Strola, G ;

Scielzo, C ;

Caligaris-Cappio, F .

BLOOD, 2003, 101 (04) :1262-1269

[8]

Representational oligonucleotide microarray analysis: A high-resolution method to detect genome copy number variation [J].

Lucito, R ;

Healy, J ;

Alexander, J ;

Reiner, A ;

Esposito, D ;

Chi, MY ;

Rodgers, L ;

Brady, A ;

Sebat, J ;

Troge, J ;

West, JA ;

Rostan, S ;

Nguyen, KCQ ;

Powers, S ;

Ye, KQ ;

Olshen, A ;

Venkatraman, E ;

Norton, L ;

Wigler, M .

GENOME RESEARCH, 2003, 13 (10) :2291-2305

← 1 →